Product logins

Find logins to all Clarivate products below.


Facial Injectables | Asia Pacific (Supplemental) | 2014 | Market Analysis

The Asia Pacific market for facial injectables will be among the most rapidly growing global markets over the next 10 years, expanding to reach a value of over $2.2 billion by 2022.

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the facial injectables market in the Asia Pacific region, including country-level data for 14 major countries and aggregate data for the rest of Asia Pacific, across a 10-year period.

Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Asia Pacific
The Asia Pacific interventional oncology device market will see strong growth through 2034, driven by updated clinical guidelines, broader access to minimally invasive cancer treatments, and…
Report
Aesthetic Injectables – Market Insights – Europe
The European aesthetic injectable market is on a strong growth trajectory. Product innovation and differentiated offerings from leading companies are expected to propel this expansion. The…
Report
Aesthetic Injectables – Market Insights – North America
The North American aesthetic injectable market is poised for sustained growth through 2034, driven by ongoing innovation and strong consumer demand. Leading global manufacturers continue to invest…
Report
Sports Medicine Devices – Market Insights – Asia Pacific
Technological investments, adoption of premium-priced products, increased market awareness through educational programs, and improved surgeon training will drive rapid growth in the Asia Pacific…
Report
Aesthetic Injectables – Market Insights – Asia Pacific
The Asia Pacific aesthetic injectable market will continue to expand through 2034, fueled by continuous innovation and the introduction of differentiated products by leading global and regional…